These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30538204)

  • 1. Crystal structure of the human NK
    Yin J; Chapman K; Clark LD; Shao Z; Borek D; Xu Q; Wang J; Rosenbaum DM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13264-13269. PubMed ID: 30538204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist.
    Cascieri MA; Ber E; Fong TM; Hale JJ; Tang F; Shiao LL; Mills SG; MacCoss M; Sadowski S; Tota MR; Strader CD
    Eur J Pharmacol; 1997 May; 325(2-3):253-61. PubMed ID: 9163573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography.
    Chen S; Lu M; Liu D; Yang L; Yi C; Ma L; Zhang H; Liu Q; Frimurer TM; Wang MW; Schwartz TW; Stevens RC; Wu B; Wüthrich K; Zhao Q
    Nat Commun; 2019 Feb; 10(1):638. PubMed ID: 30733446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping substance P binding sites on the neurokinin-1 receptor using genetic incorporation of a photoreactive amino acid.
    Valentin-Hansen L; Park M; Huber T; Grunbeck A; Naganathan S; Schwartz TW; Sakmar TP
    J Biol Chem; 2014 Jun; 289(26):18045-54. PubMed ID: 24831006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists.
    Schöppe J; Ehrenmann J; Klenk C; Rucktooa P; Schütz M; Doré AS; Plückthun A
    Nat Commun; 2019 Jan; 10(1):17. PubMed ID: 30604743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate.
    Di Fabio R; Alvaro G; Braggio S; Carletti R; Gerrard PA; Griffante C; Marchioro C; Pozzan A; Melotto S; Poffe A; Piccoli L; Ratti E; Tranquillini E; Trower M; Spada S; Corsi M
    Bioorg Med Chem; 2013 Nov; 21(21):6264-73. PubMed ID: 24075145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the effect of homocysteinylation of substance P on its binding to the NK1 receptor using molecular dynamics simulation.
    Davoudmanesh S; Mosaabadi JM
    J Mol Model; 2018 Jun; 24(7):177. PubMed ID: 29943287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging substance P receptors (NK1) in the living human brain using positron emission tomography.
    Hargreaves R
    J Clin Psychiatry; 2002; 63 Suppl 11():18-24. PubMed ID: 12562139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of T-2328, 2-fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptor.
    Watanabe Y; Asai H; Ishii T; Kiuchi S; Okamoto M; Taniguchi H; Nagasaki M; Saito A
    J Pharmacol Sci; 2008 Jan; 106(1):121-7. PubMed ID: 18187929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the N-terminal and mid-region residues of substance P in regulating functional selectivity at the tachykinin NK1 receptor.
    Perrine SA; Beard DJ; Young JK; Simmons MA
    Eur J Pharmacol; 2008 Sep; 592(1-3):1-6. PubMed ID: 18634782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPCR large-amplitude dynamics by
    Pan B; Liu D; Yang L; Wüthrich K
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2122682119. PubMed ID: 35377814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gly166 in the NK1 receptor regulates tachykinin selectivity and receptor conformation.
    Ciucci A; Palma C; Riitano D; Manzini S; Werge TM
    FEBS Lett; 1997 Oct; 416(3):335-8. PubMed ID: 9373180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P and the Neurokinin-1 Receptor: The New CRF.
    Schank JR; Heilig M
    Int Rev Neurobiol; 2017; 136():151-175. PubMed ID: 29056150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.
    Gether U; Johansen TE; Schwartz TW
    J Biol Chem; 1993 Apr; 268(11):7893-8. PubMed ID: 7681831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurokinin-1 receptor antagonists: a comprehensive patent survey.
    Huang SC; Korlipara VL
    Expert Opin Ther Pat; 2010 Aug; 20(8):1019-45. PubMed ID: 20533894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying a putative common binding site shared by substance P receptor and an anti-substance P monoclonal antibody.
    Amati V; Werge TM; Cattaneo A; Tramontano A
    Protein Eng; 1995 Apr; 8(4):403-8. PubMed ID: 7567926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprepitant (EMEND): the role of substance P in nausea and vomiting.
    Prommer E
    J Pain Palliat Care Pharmacother; 2005; 19(3):31-9. PubMed ID: 16219609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.
    Palma C; Nardelli F; Manzini S; Maggi CA
    Br J Cancer; 1999 Jan; 79(2):236-43. PubMed ID: 9888463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.
    Manak MM; Moshkoff DA; Nguyen LT; Meshki J; Tebas P; Tuluc F; Douglas SD
    AIDS; 2010 Nov; 24(18):2789-96. PubMed ID: 20975512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.